Wei Dong Wang

Patrimonio netto: 43 M $ in data 31/03/2024

65 anni

Health Technology

Consumer Services

Profilo

Fondatore di RemeGen Co., Ltd. e Yantai Rongchang Pharmaceutical Co. Ltd., Weidong Wang occupa attualmente la posizione di Presidente di Yantai Rongchang Pharmaceutical Co. Ltd. e Presidente della RemeGen Co. Si è laureato presso l'Università di Commercio di Harbin.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
REMEGEN CO. LTD. CLASS A 2.57%	28/12/2022	4 111 338 ( 2.57% )	31 M $	31/03/2024
REMEGEN CO. LTD. CLASS H 1.89%	01/10/2023	3 584 541 ( 1.89% )	12 M $	31/03/2024

Posizioni attive di Wei Dong Wang

Società	Posizione	Inizio
REMEGEN CO., LTD.	Founder	04/07/2008
Yantai Rongchang Pharmaceutical Co. Ltd.	Founder	01/03/1993
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Director/Board Member	25/06/2013

Tutte le posizioni attive di Wei Dong Wang

Formazione di Wei Dong Wang

Harbin University of Commerce

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Wei Dong Wang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
REMEGEN CO., LTD.	Health Technology

Aziende private	2
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Health Technology
Yantai Rongchang Pharmaceutical Co. Ltd.